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Toxic shock syndrome toxin 1 (TSST1)t is a 22-kD exotoxin produced by most
strains ofStaphylococcus aureus isolated from patients with toxic shock syndrome (TSS)
(1) . TSST 1 is a potent activator of monocytes and T cells . It acts on monocytes to
induce the synthesis of IL-1 and TNF (2-4) . TSSTl also triggers T cell activation
and proliferation (5), as well as the production of large amounts of various lym-
phokines such as IL-2 (6) and IFN-y (7) . The massive induction ofmonokine and
lymphokine production by TSST1 is thought to play an important role in the patho-
genesis of TSS.
A significant insight into the mechanism ofaction ofTSST 1, as well as other related
staphylococcal exotoxins, came with the observation that these toxins bind directly
to MHC class II molecules (8-11). Among the MHC class II molecules, TSST1
binds equally well with high affinity and saturation kinetics to HLA-DR and -DQ
antigens (8) . TSST1 also binds to HLA-DP alleles, albeit with a much lower affinity
than is observed for HLA-DR and -DQalleles (Scholl, P, unpublished data) . The
MHC class II-bound toxin behaves as a superantigen that interacts with T cells
via the TCR )3 chain (12, 13) to induce MHC-unrestricted T cell activation and
proliferation .
The ability ofMHC class II-boundTSST1 to engage T cells raises the possibility
that TSST1 may mimic nominal antigen in initiating cognate interaction between
T and B cells resulting in B cell proliferation and Ig production . We demonstrate
here that TSST1 induces both the proliferation of resting human B cells and their
differentiation into Ig-secreting lymphocytes . Triggering ofB cell proliferation and
differentiation byTSST1 is dependent on the presence ofT cells, and proceeds via
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MHC-unrestricted cognate T/B cell interaction involving the TCR/CD3 complex
and the MHC class II antigen/toxin complex.
Materials and Methods
ReagentsandAntibodies.
￿
TSST-1 was obtained from ToxinTechnology(Madison, WI). PHA-
P, PMA, 2-aminoethylisothiouronium bromide (AET), and ionomycin were purchased from
Sigma Chemical Co. (St. Louis, MO). Ficoll-Hypaque and Percoll were obtained from Phar-
macia Fine Chemicals (Piscataway, NJ). RPMI 1640, AB' serum, L-glutamine, penicillin,
and streptomycin were obtained from Whittaker M.A Bioproducts (Walkersville, MD). FCS
was obtained from HyClone Laboratories (Logan, UT). mAb SPVL3, directed against a
monomorphic determinant on human HLA-DQalleles, was kindly provided by Dr. Hergen
Spits (DNAX Research Institute, Palo Alto, CA). mAb ST259, directed against a mono-
morphic determinant on human HLA-DR and -DQmolecules (14), was kindly provided by
Dr. E. Yunis (Dana Farber Cancer Institute, Boston, MA). mAbs L243, directed against
monomorphic determinants on human HLA-DR molecules, OKT3 (anti-CD3), OKT4 (anti-
CD4), OKT8 (anti-CD8), and OKMI (anti-CDllb/CD18) were all generated as ascites from
their respective hybridomas (American Type Culture Collection, Bethesda, MD). mAb IOF12
directed against CD18, the common0chainofthe Leu-CAM family of adhesion molecules
(CD11a, -b, -c) was a kind gift of Dr. S. J. Burakoff (Dana Farber Cancer Institute). The
anti-CD20 mAb Leu-16 and goat anti-mouse Ig-FITC were obtained from Becton Dick-
inson & Co. (Sunnyvale, CA). [3H]Thymidine and Econofluorwere from New England Nu-
clear (Boston, MA).
Cell Preparations.
￿
Human tonsils were obtained from children undergoing tonsillectomy.
Tonsillar tissues were cut into small fragments with scissors and dispersed into single cell
suspensions. Viable cells were separated from dead cells and debris by filtering through glass
wool and by centrifugation over Ficoll-Hypaque. T cell-enriched populations were obtained
by incubating the unfractionated cells with AETtreated SRBC. Rosette-forming cells were
isolated by Ficoll-Hypaque centrifugation and the red cells were lysed with deionized water.
They were washed three times with HBSS (Microbiological Associates, Bethesda, MD),
resuspended in RPMI 1640 containing 10% AB' serum, and incubated on plastic Petri
dishes for 1 h at 37'C to remove adherent cells. The resulting T cell populations contained
>95% CD3' cells. To purify B cells, nonrosetting cells were submitted to a second rosetting
procedure. The resultant B cells were further depleted of residual T cells and monocytes by
treatment with OKT3 and OKMI, respectively, followed by rabbit complement (Pel-Freeze
Biologicals, Rogers, AR). High density B cells were then obtained by centrifugation over
a discontinuous percoll gradient (30, 45, 50, 60, and 90%) and by collecting the cells at the
interface between 50-60% layers. The resulting B cell populations contained >98% CD20'
cells and no detectable CD3' or CDIlb/CD18' cells. They did not proliferate in response
to an optimal concentration of PHA-P (10 Wg/ml), and failed to demonstrate synergistic prolifer-
ation in response to treatment with PMA and the anti-CD3 mAb OKT3 . They also failed
to produce Ig in response to PWM. All of these responses are T cell dependent, and could
be detected upon the addition of <1% T cell load to the purified B cell populations under
study (data not shown).
The T cell clone G8 is an HLA-DR5-restricted, tetanus toxoid-specific T cell clone that
was generated and maintained as described (15). Clone G8 lymphocytes exhibited no alloreac-
tivity when tested against a panel of 10 unrelated donors.
TSST-1 Binding Assay.
￿
The binding of TSST1 to purified B cellswas performed as previ-
ously described (8). TSST1 was iodinated using chloramine T and the specific activity of
labeled TSST-1 was in the range of950 Ci/mmol. B cellswere resuspended in PBS containing
1% BSA at 2.5 x 106 cells/ml. 12'I-labeled TSSTI was added at 5 x 10-9 M, and the cells
were incubated on ice for 30 min in the absence or presence of increasing concentrations
of unlabeled TSSTI. The cells were then layered over 200 pl of a mixture of phthallate oils
(1 :5 vol/vol dinonyl and dibutyl phthallate oils; Eastman Kodak, Rochester, NY) in 400-,u1
polypropylene centrifuge tubes and spun at 8,000 g for 2 min. The tips, containing the cellMOURAD ET AL.
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pellets, were cut off and counted in a gamma counter. The affinity of TSST-1 binding to
B cells and the number of binding sites were determined by Scatchard analysis of the data.
To study the inhibition ofTSST1 binding to B cells by mAbs directed against B cell surface
antigens, cells were incubated with 1251-labeled TSST1 and 10-8 M in the absence or in the
presence of the indicated mAb, used at a concentration of 6.7 x 10-s M (10 hg/ml).
Nonspecific binding was determined by adding excess unlabeled TSST-1 (10-6 M). The in-
cubations were carried out for 30 min on ice, following which, the cells were processed and
the specific binding was determined as described above.
Assaysfor B Cell Proliferation and Ig Production. For proliferation assays, B cells were cul-
tured in 96-well flat-bottomed plates (Nunc, Roskilde, Denmark) at 105 B cells/well sus-
pended in 200 p,l RPMI 1640 medium supplemented with 10% FCS, 100 U/ml streptomycin,
100 U/ml penicillin, and 2 MM L-glutamine. Cells were cultured for 48 h at 37°C in a 5%
CO2 humidified atmosphere in the absence or presence of the indicated stimuli and/or ir-
radiated autologous T cells or irradiated clone G8 cells, (3,000 rad). Cells were then pulsed
with [3H]thymidine at 1 kci/well and were further cultured for an additional 16 h. There-
after, the cells were harvested, and [3H]thymidine incorporated into cellular DNA was
counted.
For Ig production, B cells were cultured in 12 x 75-mm tubes at 106 B cells/ml of culture
medium containing the appropriate stimulus and various numbers of irradiated autologous
T cells or irradiated G8 cells (3,000 rad). After 7 d of culture, supernatants were collected,
and IgG and IgM synthesis was determined by ELISA, as previously described (15).
In some experiments, B cells were cultured in 24-well flat-bottomed plates (Nunc) at 106
cells/ml/well in the presence or absence of TSSTI. 106 Irradiated T cells/well, supplemented
with 10% irradiated B cells as accessory cells, were cocultured with B cells either mixed to-
gether or separated by placing the T cells inside Millicell-HA well inserts (Millipore Corp.,
Bedford, MA). The two compartments were separated by a 0 .4-um membrane, allowing free
diffusion of soluble mediators. The proliferative responses were assessed on day 3, and Ig
production on day 7, as described above.
Results
TSST-1 Binds to MHC-Class II Molecules on High Density Tonsillar B Cells.
￿
Purified
dense tonsillar B cells were incubated with 1251-labeled TSSTI in the presence of
increasing concentrations of unlabeled toxin, and the resulting binding data were
subjected to Scatchard analysis. Fig. 1 demonstrates that TSST-1 binds to B cells
with high affinity (Kd = 3.1 x 10-s M) and saturation kinetics (76,000 sites/cell).
The binding of 12'1TSSTI to B cells was significantly inhibited by the anti-HLA-
DR mAb L243, and to a lesser degree by the anti-HLA-DQmAb SPVL3, but not
by the anti-HLA-DR and -DQmAb ST259, or by the anti-CD20 mAb Leu-16. The
combination of L243 and SPVL3 mAbs inhibited the binding of TSST-1 to B cells
to an extent comparable with that achieved with excess unlabeled toxin (Fig. 2).
TSST-1 Induces B CellProliferation andIgProduction in a T Cell-dependentManner .
￿
We
next examined the capacity ofTSST-1 to trigger B cell proliferation and Ig produc-
tion. Because TSST-1 is a potent T cell mitogen, the B cells were rigorously purified
to rule out any contribution from contaminating T cells to the responses under study.
Fig. 3 demonstrates that TSSTI on its own failed to induce the proliferation ofpurified
B cells. However, in the presence of irradiated T cells, TSSTI successfully triggered
the proliferation of purified B cells. Significant proliferation was observed upon the
addition of 5 % irradiated T cells, and the maximal response was noted at the highest
ratio of T/B cells tested (1 :1).
TSSTI also induced T cell-dependent differentiation of B cells into Ig-secreting2014
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FIGURE 1 .
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Binding of TSST 1 to high
density tonsillar B cells . B cells were in-
cubated with 1251-TSST at 5nM, andun-
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FIGURE 2 .
￿
Inhibition of binding of
TSST 1 to dense tonsillar B cells by
MHC class II mAbs . Cells were in-
cubated with 1251TSST at 10 nM .
Nonspecific bindingwas determined in
the presence of 10-6 M unlabeled
TSST 1 . mAbs were added at a final
concentration of 6.7 x 10-s M (10
hg/ml) . Similar results were obtained
in two other experiments .
FIGURE 3 .
￿
Induction of T cell-depen-
dentB cell proliferation by TSST1.B cells
were cultured with the indicated loads of
irradiated autologousT cells in the absence
or in the presence of TSST1, used at 1
Ecg/ml . Results represent means of tripli-
cate cultures +/- SD. Similarresults were
found in five other experiments .
lymphocytes . Fig. 4 demonstrates that, in the absence ofT cells, TSST1 failed to
initiate Ig synthesis by purified B cells. However, in the presence of irradiated autol-
ogous T cells, TSST1 induced resting B cells to synthesize large amounts of IgG
and IgM. Ig production induced by TSST1 was critically dependent on the pres-
ence ofan optimal number ofTcells in culture withB cells . Maximal Ig productionMOURAD ET AL .
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FIGURE 4 .
￿
TSST-1 inducesTcell-dependent IgM
(A) and IgG (B) synthesis in B cells. B cells were cul-
tured with the indicated loads of irradiated autolo-
gousT cells in the absence or in thepresence ofTSST
1, used at 1 wg/ml . The results are expressed as net
Ig synthesis in TSST1-stimulated cultures as com-
pared with control, unstimulated cultures, and rep-
resent means ofduplicate determinationsfrom dupli-
cate cultures . Similar results were found in five other
experiments .
was noted in the presence of 20% irradiated T cells, and progressively decreased
upon the addition of higher numbers of T cells (Fig. 4) .
TSSTI-triggeredB Cell Responses Require Physical TIB Cell Interaction.
￿
TheT cell re-
quirement for the induction ofB cell proliferation by TSST1 could not be replaced
by solubleT cell factors . Addition of various cytokines, including IL-1, IL-2, IL-4,
IL-5, IL-6, IFN-y, andTNFa, alone or in combination, or of supernatants (diluted
1 :2 to 1 :20) derivedfrom TSST1-activated Tcells, failed to supportTSST1-triggered
B cell proliferation (data not shown) . These results suggested that T/B cell contact
was required for the induction of B cell proliferation by TSST1.
To assess whether a short-range or labile mediator could substitute forTB cell
contact, we examined the capacity of TSST1 to trigger B cell proliferation and Ig
production upon separating the T cells from the B cells by means ofa well insert
with a 0.4-jAm membrane that allowed the diffusion of soluble molecules . The T
cells in this experiments were placed inside the well insert and were activated by
adding TSST1 and accessory cells in the form of irradiated B cells . Fig. 5 shows
that B cells thus separated fromT cells failed to proliferate in response to TSST1 .
In contrast, the same B cells proliferated to TSST 1 when they were mixed together
with the T cells. Similar results were obtained for the induction ofIgM and IgG
production by TSSTl (Fig . 6) . These results indicate that TB cell contact was re-
quired forTSST1 to induce B cell proliferation and Ig secretion .
Elect ofmAbs againstLymphocyte Surface Antigens on TSST-1-inducedB Cell Proliferation
andIg Production. The surface antigens mediating theTB cell interactions under-
lyingthe TSST1-triggered Bcell responses were identified byexamining the ability2016
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FIGURE 5 .
￿
TSST-1-triggered B cell
proliferation requires intimateTB cell
contact . B cells were cultured with ir-
radiated autologous T cells, used at a
1 :1 TB cell ratio, either mixed together
or separated by placing the T cells in
a 0.4-gm well insert .TSST1 wasadded
at 1 ug/ml . Results aremeans oftripli-
cate determinations +/- SD. Similar
results were obtained in one other ex-
periment .
ofmAbs directed against T and B cell antigens to inhibit these responses (Figs. 7
and 8) . Using this approach, theTCR/CD3 complex, as well asMHC class II an-
tigens, were found to be critically important forthe progressionofTSST1-triggered
B cell responses . The anti-CD3 mAbOKT3 was highly effective in inhibiting both
TSST1-triggered B cell proliferation and Ig production . The anti-HLA-DR mAb
L243, which was effective in inhibiting TSST1 binding to B cells, also inhibited
TSST1-triggered B cell functional proliferation and Ig production . The anti-HLA-
DQ mAb SPVL3, which synergized with mAb L243 in inhibiting the binding of
TSST-1 to B cells, was found to enhance the inhibition of TSST-1-triggered B cell
responses . Three other mAbs to HLA-DR (L227, P4.1, and 2.06), all of which are
FIGURE 6 .
￿
TSST1-triggered Ig production requires
intimate T/B cell contact . B cells were cultured with
irradiated autologous T cells (at a0.2 TB cell ratio)
either mixed together or separated by placing theT
cells in a 0.4-, well insert. TSST-1 was added at 1
jig/ml . The results represent means of duplicate de-
terminations from duplicate cultures. Similar results
were found in one other experiment .MOURAD ET AL.
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FIGURE 7 .
￿
Inhibition ofTSST
1-triggered B cell proliferation
by mAbs directed againstT and
B cell antigens. B cells were cul-
tured in the presence of irradi-
ated autologousT cells at aTB
cell ratio of 1 :1 . TSSTl was
added at 1 jig/ml, and the indi-
cated mAbs were added at a
final concentration of 10 wg/ml.
Results are presented as means
of triplicate determinations
+/- SD . Similar results were
found in two other experiments.
FIGURE 8 .
￿
Inhibition of TSST1-triggered Ig
production by mAbs directed against T and B
cell antigens. B cells were cultured in the pres-
ence ofirradiated autologousT cells at aT/B cell
ratioof0.2:1 .TSSTI wasaddedat 1 F+g/ml, and
the indicated mAbs were added at a final con-
centration of 10Wg/ml .Theresults areexpressed
as net Ig synthesis in TSST1-stimulated cultures
as compared with control, unstimulated cultures,
and representmeans ofduplicate determinations
from duplicate cultures . Similar results were
found in one other experiment.
known to inhibitTSST1 binding to B cells (8), also inhibited TSST1-triggered B
cell responses(datanot shown) . In contrast, theanti-HLA-DRand-DQmAb ST259,
which had no effect on the binding ofTSST1 to B cells, failed to inhibit TSST1-
triggered B cell responses . TSST1-triggered B cell proliferation and Ig production
also required theparticipation ofCDllaJCD18 moleculesforoptimal responses. The
anti-CD18mAb 1OF12 significantly inhibited TSST1-triggered B cell proliferation,
and, to a lesser extent, Ig production . The specificity of the inhibitory effects ob-
served with the above-mentioned mAbswasdemonstrated by the inability ofmAbs
directed againstothersurface antigens, includingtheT cell antigens CD4andCD8
and theB cell surface antigen CD20, to inhibit TSST1-triggered B cell responses.
TSSTI-mediated TIB Cell InteractionsAreMHC Unrestricted.
￿
We next examined the2018
￿
SUPERANTIGEN-MEDIATED COGNATE T/B CELL INTERACTION
TABLE I
TSST-1-mediated TIB Cell Interaction Is MHC Unrestricted
TSST-1-triggered B cell proliferation and Ig production is supported by clone
G8, an allogeneic, nonalloreactive Tcell clone. For proliferation studies, B cells
were cultured in the presence of irradiated clone G8 lymphocytes at aT/B cell
ratio of 1 :1 . For Ig production, a T/B cell ratio of 0.2 :1 was used.
MHC restriction of TSST-1-mediated TB cell interaction. For this purpose, we ex-
amined thecapacity ofthenonalloreactive Tcell cloneG8 to supportTSST1-mediated
B cell activation. Clone G8 proliferated when stimulated with TSST1 in the pres-
ence of autologous or allogeneic monocytes or in the presence of purified B cells
obtained from twodifferent tonsils (datanotshown). B cells from the same twotonsils
were examined for their capacity to proliferate and to secrete Ig in the presence of
irradiated cloneG8 cells. TableI shows that whileneitherTSST1 norclone G8 could,
on theirown, induce B cell proliferationor Ig production, vigorous B cellsprolifera-
tion and Ig production were observed when both clone G8 and TSST1 were added
to B cell cultures. These results indicate that TSST1-mediated T/B cell interaction
is MHC unrestricted.
Discussion
Antigen-driven B cell activation and differentiation is a T cell-dependent process
requiringcognateinteraction between theTCR/CD3 complexandantigen presented
in the contextofMHC class II molecules on the surface ofB cells (16). This interac-
tion is restricted both by the ability of a B cell to present antigen in the context of
the appropriate MHC allele and by the availability in the T cell repertoire of V
elements able to recognize the antigen MHC class II complex. These restrictions
complicate the study of antigen-driven cellular interactions between unprimed T
and B cells. In this study, we describe the induction of polyclonal B cell activation
and differentiation by the staphylococcal exotoxin superantigen TSST1. TSST1 binds
with high affinity and with saturation kinetics to MHC class II antigens on high
density tonsillar B cells. By itself, TSST1 did not cause B cell proliferation or Ig
production. However, in thepresence of irradiated T cells, TSST1 induced the prolifer-
ation of B cells and their differentiation into Ig-secreting lymphocytes. TSST1-
dependent B cell proliferation progressively increased as a function of the load of
irradiated cells added. In contrast, TSST1-induced Ig production was critically de-
pendent on the presence of an optimal load of T cells in culture with the B cells.
Optimal Ig production was achieved at 1:5 irradiated T cell/B cell ratio. Higher
T cell loads resulted in progressive decline in TSST1-induced Ig production. This
[3H]Thymidine Ig production
incorporation Medium TSST-1
Exp. Medium TSST-1 IgM IgG IgM IgG
cpm nglml
1 B cells 188 252 160 190 200 215
B cells + clone G8 807 47,256 150 200 1,450 3,000
2 B cells 221 179 180 220 200 210
B cells +clone G8 859 32,541 185 250 2,650 2,800MOURAD ET AL.
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result may help explain the observation that TSST1 inhibits spontaneous as well
as PWM-induced Ig production in unfractionated PBMC (17). It is possible that
inhibitory TB cell interactions dominate at higher T cell loads. Alternatively, mas-
sive activation ofa large number ofT cells by TSST1 may result in the attainment
ofa critical concentration ofcytokine(s)inhibitory forTSST1-triggered Igproduc-
tion. Experiments are under way to further identify the mechanism(s) underlying
this inhibition.
TSST1-triggered B cell responses were strictly dependent on the presence ofT
cells in physical contactwith B cells. Separation ofTand B cells by means of a 0.4-
Am membrane thatinhibited TBcellcontact while allowing thediffusion ofsoluble
mediators abrogated TSST1-triggered Bcell responses. TherequirementforTcells
could not bebypassed bytheaddition ofrecombinant cytokines invariouscombina-
tions or by the addition of culture supernatants of TSST1-activated T cells.
The T/B cell interactions underlying TSST1-triggered B cell responses were pri-
marily mediated by the MHC class II/toxin complex on B cells and the TCR/CD3
complex on T cells. This was evidenced by the inhibition ofTSST1-induced B cell
responses by both an anti-CD3 mAb and by a combination of anti-MHC class II
mAbs thatinterfered with the binding ofTSSTl to B cells. Additional intercellular
adhesive interactions, mediated byCD11a/CD18, were alsorequired foroptimalTSST
1-triggered B cell proliferation and Ig production. OtherTand B cell antigens, in-
cluding CD4, CD8, and CD20, were not demonstrated to play a significant role
in TSST1-triggered B cell responses. The failure ofmAbs directed against CD4 or
CD8 to influence TSST1-triggered B cell responses is in agreement with previous
reports showingthat TSST1 induces the activationofboth CD4+ and CD8+ T cell
subsets, as well as CD4-/CD8- T lymphocytes (18).
Overall, these results support the notion that TSST1 initiates, upon its binding
to MHC class II molecules, a cognate interaction between T and B cells mediated
by TCR/CD3 and MHC class II/toxin complex. This view is strengthened by the
observation that T cell triggering by MHC class II/toxin complex is preferentially
restricted to particular vfl families, suggesting that upon its binding to MHC class
II molecules, TSST1 engages the VO chain on the TCR (12, 13). In this scheme
ofevents, MHC class II molecules would primarily function to bind and present
TSST1 to T cells. However, an additional direct interaction between MHC class
II molecules and the TCR cannot be ruled out.
The TB cell interaction initiated upon the binding of TSSTl to MHC class II
molecules is similar in many aspects to nominal antigen-mediated cognate TB cell
interaction. They are both driven by interaction between the TCR/CD3 complex
on T cells and the MHC class II molecules on B cells, and they both require the
contribution of additional adhesive interactions mediated by CDlla/CD18 (16, 19,
20). However, unlike the case with nominal antigen (19), TSST1-mediated TB cell
interactiondoes not requiretheparticipationofCD4. Thismayreflectthehigh affinity
nature oftheinteractionbetweentheMHC classII/toxincomplex and theTCR/CD3
complex as CD4 functions to bolster low affinity but not high affinity antigenTCR
interactions (21). Another distinction between antigen- and TSST1-triggered T/B
cell interactions is that the latter isnot restricted to a particular MHC class II allele
and can proceed between histoincompatible T and B cells. This was illustrated by
the ability ofa nonalloreactive T cell clone to support, in the presence of TSST1,2020
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theproliferation ofallogeneic B cellsandtheir differentiation into Ig-producing lym-
phocytes. The ability ofTSST1 to mediate MHC-unrestricted cognate interaction
between large numbers ofunprimed T and B cells provides a useful model for the
study ofantigen-driven, Tcell-dependent B cell proliferation and Ig production.
TSST1-mediated T/B cell interaction initiates a series ofevents in both T and
B cells culminating in B cell activation and Ig production. It has been pointed out
that activation ofthe engaged T cells by means ofcrosslinking their TCR/CD3 is
the primaryobligate step in theprocess ofinitiating Tcell-dependent B cell activa-
tion (22-24). In this regard, TSST1, complexed with MHC class II antigens and
arrayed on the surface of B cells, would be expected to effectively crosslink the
TCR/CD3 molecules ofthe engaged T cells. This would result in the reorientation
ofthe microtubule organizing center and the Golgi apparatus ofthe engaged T cells
to face B cells, similarto what is observed for antigen-driven cognate T/B cell inter-
action (25, 26). These changes would help target the secretory products of the en-
gaged Tcells, inparticular, lymphokinesand growth factorscrucialfor B cell growth
and differentiation, for delivery at the site of T/B cell contact (27).
In addition to triggering Tcell activation andcytokine production, TSSTI-mediated
T/Bcell interactionmay alsodeliver trophic signals to Bcells viatheengaged MHC
class II molecules. The function of MHC class II molecules as signal transducers
has been well documented. mAbs to MHC class II antigens modulate the prolifera-
tion and Ig production ofB cells triggered with a variety of mitogens (28, 29). En-
gagement ofMHC class II molecules by mAbs is associated with the accumulation
ofthe second messenger cAMP and the translocation ofprotein kinase C from the
cytosol to the nuclei oftreated B cells (30). Evidence presented elsewhere (Mourad,
W, T. Chatila, andR. S. Geha, manuscriptsubmitted forpublication) demonstrates
that TSSTI synergizes with antibodies to surface IgM to induce vigorous B cell
proliferation. This suggests that TSSTI transduces a signal through MHC class
II antigens that allows the progression ofpreactivated B cells through the cell cycle.
The nature of these signals and the role they play in TSST1-triggered B cell re-
sponses requires further investigation.
Summary
The Staphylococcus aureus exotoxin toxic shock syndrome toxin 1 (TSSTI) is a po-
tent activatorofT cellsand monocytes. Wehave recently demonstrated thatTSST1
is a superantigen that binds monomorphic determinants on MHC class II mole-
cules. In the present study, we have examined the effect ofTSSTI on the activation
and differentiation of high density human tonsillar B cells. TSSTI bound to ton-
sillar B cells with high affinity and saturation kinetics. This bindingwas effectively
inhibited by a combination ofanti-HLA-DR and anti-HLA-DQmAbs. Treatment
ofpurified B cellswithTSST1 failed to induce B cellproliferation orIgproduction.
However, in the presence ofirradiated T cells, TSSTI induced resting B cells to
proliferate and differentiate into Ig secretory cells. TSSTI mimicked nominal an-
tigen in thatits induction ofB cell responseswas strictlydependent on physical con-
tact between T and B cells, and was profoundly inhibited by anti-MHC class II
mAbs, anti-CD3 mAbs, and, to a lesser extent, by anti-CD18 mAbs. However, un-
like nominalantigen, TSST1-mediatedT/B cellinteractions were MHC unrestricted.These results suggest that TSST1 induces T cell-dependent B cell proliferation and
differentiation by virtue of its ability to mediate MHC-unrestricted cognate TB
cell interaction via the TCR/CD3 complex and MHC class II antigens.
Receivedfor publication 21 July 1989.
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